Day: January 13, 2025

Spear Bio Secures FDA Breakthrough Device Designation for its Novel pTau 217 Blood Test, Advancing Scalable Solutions for Early Alzheimer’s Disease Diagnosis

WOBURN, Mass., Jan. 13, 2025 /PRNewswire/ -- Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that...

Helix Partners with Komodo Health, Combining Helix’s Clinico-Genomic Datasets with Komodo’s Healthcare Map® for Clinical & Research Impact

SAN MATEO, Calif., Jan. 13, 2025 /PRNewswire/ -- Helix, a leader in population genomics and precision health, and Komodo Health,...

Waystar unveils transformative generative AI innovation to help providers recover billions of dollars tied to 450 million annual denied claims

Healthcare providers gain access to first-of-its-kind generative AI technology, leading to faster and more accurate payments LEHI, Utah, and LOUISVILLE,...

EMA Wellness Bolsters Executive Leadership to Support Growing Global Demand for a Singular Clinical Trial Data, Analytics and Adjudication Platform

New CEO, Chief Business Officer and Executive Advisors bring track records of driving growth and innovation in successful clinical trials...

error: Content is protected !!